I recently wrote about Apple’s pending petition to the Supreme Court on the NHK-Fintiv Rule. Now Mylan Labs has followed up with an additional petition focusing on the same issues:
- Does the no-appeal provision of 35 U.S.C. § 314(d) “categorically preclude appeal of all decisions not to institute inter partes review?”
- Is the NHK-Fintiv Rule substantively and procedurally unlawful?
Mylan Labs. Ltd. v. Janssen Pharmaceutica, N.V. (Supreme Court 2021) [Petition]
Source: https://patentlyo.com/patent/2021/08/fintiv-supreme-court.html
More from Patently-O
Law School Canons: Ford – The New Personal Jurisdiction Quick Reference Guide
Source Node: 874454
Time Stamp: May 25, 2021
Marks IP Fellowship at George Washington University – Open for Fall 2021
Source Node: 1018965
Time Stamp: Aug 9, 2021
FRANCE.COM: Trademark Transferred to French Government without Recourse in US Courts
Source Node: 1118218
Time Stamp: Oct 5, 2021